BRASKEM SA (BAK): Financial results for Q2 2026
BRASKEM SA (BAK) furnished an SEC Form 6-K — earnings release. CONTENTS 1. KEY INDICATORS 6 2. EXECUTIVE SUMMARY 7 3. PERFORMANCE BY SEGMENT 2Q26 8 3.1 BRAZIL/SOUTH AMERICA 8 3.2 RENEWABLE ENERGY OVERVIEW 11 3.3 UNITED STATES AND EUROPE 12 3.4 MEXICO 14 4. CONSOLIDATED FINANCIAL OVERVIEW 16 4.1 CONSOLIDATED REVENUE 16 4.2 COST OF GOODS SOLD
How this was made
The 30-second read
Why it matters
The earnings show resilient profitability with $1 bn recurring EBITDA and strong cash generation, suggesting the company can weather feedstock volatility.
Market read
Braskem's solid Q2 results provide a positive signal for the petrochemical sector and may influence commodity‑linked equities.
What to watch
Potential impact of Alagoas geological litigation on future cash flows.
Braskem reports Recurring EBITDA of approximately US$1.0 billion in 2Q26, driven primarily by higher chemical and petrochemical spreads in international markets.
Recurring EBITDA and net income rose sharply on stronger international spreads and REIQ-related feedstock credits, but liquidity and capital-structure risks remained acute, with US$9.5 billion of adjusted net debt, 6.74x corporate leverage, defaults under certain financial instruments in July 2026, and credit ratings of C from Fitch and D from S&P.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Consolidated Recurring EBITDAother | US$1,043 million (R$5,253 million) | an increase of US$852 million (R$4,248 million) compared to 1Q26 | – |
| Consolidated gross profit increaseother | US$845 million (R$4,216 million) | increase compared to 1Q26 | – |
| Net income attributable to shareholdersother | US$664 million (R$3.3 billion) | an increase compared to 1Q26 | – |
| Other income (expenses), netother | R$4 million | – | – |
| Operating cash flowother | R$1,928 million | higher than the operating cash consumption in 1Q26 | – |
| Operating cash flowother | US$385 million | – | – |
| Recurring cash generationother | approximately R$1,048 million | – | – |
| Recurring cash generationother | approximately R$1.1 billion | higher than the R$4.7 billion consumption in 1Q26 | – |
| Cash generation before debt serviceother | R$807 million | – | – |
| Consumption of cash and cash equivalentsother | R$748 million | – | – |
| Corporate gross debt balanceother | US$10.3 billion | – | – |
| Adjusted net debt balanceother | US$9.5 billion | a 3% increase compared to the previous quarter | – |
| Corporate leverageother | 6.74x | – | – |
| Long-term foreign exchange hedge purchased puts outstanding notional amountother | US$98 million | – | – |
| Long-term foreign exchange hedge purchased puts average strike priceother | R$/US$5.23 | – | – |
| Long-term foreign exchange hedge sold calls outstanding notional amountother | US$64.5 million | – | – |
| Long-term foreign exchange hedge sold calls average strike priceother | R$/US$7.93 | – | – |
| Zero Cost Collar mark-to-marketother | positive by R$11.2 million | – | – |
| Options exercised positive cash effectother | R$49.2 million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Brazil/South AmericaHigher average international price references for resins and main chemicals, higher main-chemical export volumes, commercial captures, and PIS/COFINS credits under the REIQ program. | not reported | increased in U.S. dollars (51%) and in reais (45%) compared to 1Q26, excluding REIQ Investments effects | increased in U.S. dollars (+35%) and in reais (+20%) compared to 2Q25, excluding REIQ Investments effects |
| United States and EuropeHigher international PP price references in the United States and Europe and a 3 thousand tons, or 1%, increase in PP sales volumes. | not reported | higher in U.S. dollars (+44%) and in Brazilian reais (+38%) compared to 1Q26 | higher in U.S. dollars (+47%) and in Brazilian reais (+30%) compared to 2Q25 |
| MexicoHigher international PE price reference in the United States, partly offset by lower PE sales volumes. | not reported | higher in U.S. dollars (+48%) and in Brazilian reais (+42%) compared to 1Q26 | higher in U.S. dollars (+27%) and in Brazilian reais (+13%) compared to 2Q25 |
2026 outlook
- NoteInvestments expected to be made by Braskem in 2026 (excluding Braskem Idesa and REIQ Investments) total US$465 million (R$2.6 billion).
- NoteBraskem Idesa’s planned investments for 2026 total US$42 million (R$234 million).
What drove it
- Consolidated Recurring EBITDA benefited from higher chemical and petrochemical spreads in international markets and commercial captures.
- Average international spreads for resins and main chemicals in Brazil/South America increased 82% and 98%, respectively, compared to 1Q26.
- The average international PP spread in the United States and Europe increased 28% compared to 1Q26.
- The average international PE spread in Mexico increased 73% compared to 1Q26.
- Brazil/South America gross profit also benefited from US$115 million (R$578 million) related to REIQ Raw Material on feedstock purchases.
- Brazilian resin demand increased +3% compared with 1Q26, led by PVC demand of +11% and PP demand of +2%.
- Mexico PE sales volumes declined 15 thousand tons (-11%) from 1Q26 and 30 thousand tons (-20%) from 2Q25.
- Green PE and ETBE net sales revenue increased +46% from 1Q26, mainly due to a 49% increase in Green PE sales volumes.
Concerns
- The company and its advisors continued discussions with creditors and had received purely indicative and non-binding proposals on a potential Restructuring; no decision had been made regarding terms or additional judicial or other measures as of the release date.
- In July 2026, the Company was in default under certain financial instruments after the end of applicable cure periods and the non-payment of other financial obligations whose payments were suspended.
- Balances of financial obligations in default will be classified as current liabilities as from July 2026.
- Fitch revised the global credit rating to C and S&P revised it to D on June 26, 2026.
- The conflict in the Middle East increased feedstock costs and international prices, but expectations of a potential ceasefire negatively affected global demand and returned international resin spreads by the end of the quarter to levels observed before the conflict.
- The Company recognized an additional provision related to the Alagoas geological event of approximately US$20 million (R$100 million).
- Potential future Alagoas actions may result in significant additional costs and expenses that may differ from current estimates and provisions.
What to watch
- Execution and outcome of negotiations with financial creditors on a consensual, structural and orderly Restructuring.
- Liquidity effects from suspended financial-obligation payments, current-liability classification of defaulted obligations, letter-of-credit reimbursement obligations, and reduced payment arrangements.
- Whether international resin and chemical spreads remain above pre-conflict levels after they returned to those levels by the end of 2Q26.
- The pace of Transformation Program benefits, commercial initiatives, operational efficiency measures, and capital-allocation discipline focused on preserving liquidity.
- Braskem Idesa's negotiations with holders of its 2029 and 2032 bonds and potential judicial measures, including Chapter 11 under U.S. law.
- Further provision changes, disbursements, legal proceedings, and remediation requirements related to the Alagoas geological event.
Balance sheet and cash flow
- Operating cash flow was R$1,928 million in 2Q26.
- Recurring cash generation totaled approximately R$1,048 million.
- Cash generation before debt service was R$807 million in 2Q26.
- Consumption of cash and cash equivalents at the end of 2Q26 was R$748 million.
- Corporate gross debt balance was US$10.3 billion as of June 30, 2026.
- Adjusted net debt balance was US$9.5 billion and corporate leverage was 6.74x.
- Corporate debt denominated in foreign currency represented 92% of the Company's total debt.
- R$929 million (US$179 million) in trade obligations secured by letters of credit were settled during the period by certain issuing financial institutions directly to suppliers.
- Letters of credit in the approximate amount of R$703 million (US$136 million) matured and were settled by certain issuing financial institutions in July 2026.
- Advances to suppliers totaled R$1,625 million as of June 30, 2026 (2025: R$544 million).
Analysis
Braskem reported a major sequential earnings recovery in 2Q26. Consolidated Recurring EBITDA reached US$1,043 million (R$5,253 million), up US$852 million (R$4,248 million) from 1Q26, while net income attributable to shareholders was US$664 million (R$3.3 billion). The improvement was led by higher international chemical and petrochemical spreads following feedstock-supply constraints associated with the Middle East conflict. Consolidated gross profit increased US$845 million (R$4,216 million) from 1Q26, and the Brazil/South America business received an additional US$115 million (R$578 million) benefit from REIQ Raw Material credits.
All three reported operating regions posted higher Recurring EBITDA than both 1Q26 and 2Q25. Brazil/South America delivered US$869 million (R$4.4 billion), supported by stronger resin and main-chemical spreads, commercial captures and REIQ-related effects. United States and Europe produced US$147 million (R$739 million), with international PP spreads up 28% from 1Q26. Mexico contributed US$57 million (R$289 million), as a 73% increase in international PE spreads from 1Q26 outweighed reduced sales volumes and a lower utilization rate.
Cash flow improved with operating cash flow of R$1,928 million, recurring cash generation of approximately R$1,048 million, and cash generation before debt service of R$807 million. Working capital nevertheless absorbed cash because of feedstock-price volatility, higher inventory volumes, and reduced availability of certain payment arrangements. Braskem also reported R$748 million of cash and cash-equivalents consumption at quarter end. Investment plans for 2026 remained US$465 million (R$2.6 billion) for Braskem excluding Braskem Idesa and REIQ Investments, plus US$42 million (R$234 million) for Braskem Idesa.
The balance-sheet and restructuring situation remained the central risk. Corporate gross debt was US$10.3 billion, adjusted net debt was US$9.5 billion, and corporate leverage was 6.74x. Certain financial obligations entered default in July 2026 after cure periods ended, and related balances will be classified as current liabilities from July. Fitch and S&P revised the global credit rating to C and D, respectively, on June 26, 2026. The Company continued to evaluate non-binding creditor proposals, without an agreed restructuring or determination on further judicial or extrajudicial actions.
Market conditions also weakened into the end of the quarter. Management said expectations of a Middle East ceasefire negatively affected global demand and that international resin spreads returned by quarter-end to levels seen before the conflict. In addition, the Company recognized an approximately US$20 million (R$100 million) additional Alagoas provision, while stating that the eventual scope and cost of future measures and claims cannot be estimated. The second-half priorities are therefore centered on restructuring, liquidity preservation, cash generation, operational competitiveness and completion of the Transformation Program's value-generation mapping.
Not in the filing
stated, not guessed- Consolidated revenue amount and prior-period revenue amounts were not provided in the supplied text.
- Reported segment revenue amounts were not provided in the supplied text.
- Gross margin was not provided in the supplied text.
- Operating income was not provided in the supplied text.
- GAAP and non-GAAP EPS were not provided in the supplied text.
- GAAP and non-GAAP diluted-share counts were not provided in the supplied text.
- Income-tax expense and tax rate were not provided in the supplied text.
- Free cash flow was not provided in the supplied text.
- Cash and cash equivalents balance was not provided in the supplied text; only consumption of cash and cash equivalents was provided.
- Capital returns, including dividends and share repurchases, were not provided in the supplied text.
- Prior-year and prior-quarter reported values for consolidated net income, operating cash flow, debt, and most other key metrics were not provided on their respective line items.
- No revenue, margin, operating-expense, or tax-rate outlook was provided.
- No named executive quotations were provided.
- The accounting framework, including whether results are IFRS, was not stated in the supplied text. Segment revenue fields are marked 'not reported' because the required schema does not permit null values.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Q2 2026 earnings released by Braskem amid volatile macro environment driven by Middle East conflict and feedstock price swings.
Ticker impact
Braskem posted recurring EBITDA of about $1.0 billion for Q2 2026.
Potential upside of 3‑5% in BAK stock if market reacts favorably.
Large EBITDA beat and solid cash flow suggest better‑than‑expected margins, likely to lift price.
Market effects
Resins and petrochemical sector may gain price support from higher spreads.
Brazilian market could benefit from Braskem's results, bolstering local indices.
Signals continued demand for petrochemicals amid Middle East conflict, relevant to global commodity markets.
Counterpoint
Higher feedstock volatility could erode margins, risking a pullback in Braskem shares.
Key entities
- companyBraskem SA
Largest resin producer in the Americas, listed on NYSE as BAK.
- stakeholderCreditors
Groups providing indicative restructuring proposals to Braskem.
